Prm Drug Discovery And Development LLC is categorized under Business Consultants in Ledyard, CT and active since 2010.
Prm Drug Discovery And Development LLC was established in 2010, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Paul R Mcguirk at the company’s single location by writing to 8 Lynn Drive, Ledyard, Connecticut CT 06339 or by phoning (860) 625-9179. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Prm Drug Discovery And Development LLC |
| Contact Person: | Paul R Mcguirk |
| Address: | 8 Lynn Drive, Ledyard, Connecticut 06339 |
| Phone Number: | (860) 625-9179 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Prm Drug Discovery And Development LLC was started in 2010 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Paul R Mcguirk for inquiries that concern Prm Drug Discovery And Development LLC by calling the company number (860) 625-9179, as your correspondence is most welcome. Additionally, the physical location of the single location of Prm Drug Discovery And Development LLC can be found at the coordinates 41.457103,-72.004591 as well as the street address 8 Lynn Drive in Ledyard, Connecticut 06339.
For its online presence, you may visit Prm Drug Discovery And Development LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.